dc.date.accessioned2019-01-25T17:00:26Z
dc.date.available2019-01-25T17:00:26Z
dc.date.created2019-01-25T17:00:26Z
dc.date.issued2016
dc.identifierhttps://hdl.handle.net/20.500.12866/4920
dc.identifierhttps://doi.org/10.1139/bcb-2016-0066
dc.description.abstractLactoferrin (Lf) is the major whey protein in milk, with multiple beneficial health effects including direct antimicrobial activities, anti-inflammatory effects, and iron homeostasis. Oral Lf supplementation in human preterm infants has been shown to reduce the incidence of sepsis and necrotizing enterocolitis. In preclinical models of antenatal stress and perinatal brain injury, bovine Lf protected the developing brain from neuronal loss, improved connectivity, increased neurotrophic factors, and decreased inflammation. It also supported brain development and cognition. Further, Lf can prevent preterm delivery by reducing proinflammatory factors and inhibiting premature cervix maturation. We review here the latest research on Lf in the field of neonatology.
dc.languageeng
dc.publisherNRC Research Press
dc.relationBiochemistry and Cell Biology
dc.relation1208-6002
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHumans
dc.subjectAnimals
dc.subjectCattle
dc.subjectbrain
dc.subjectcerveau
dc.subjectinfection
dc.subjectlactoferrin
dc.subjectlactoferrine
dc.subjectprematurite
dc.subjectprematurity
dc.subjectAnti-Infective Agents/pharmacology
dc.subjectInfant, Premature/metabolism
dc.subjectLactoferrin/pharmacology
dc.titleLactoferrin and prematurity: a promising milk protein?
dc.typeinfo:eu-repo/semantics/review


Este ítem pertenece a la siguiente institución